Siu LL - Search Results

1

Phase 1 trial design: is 3 + 3 the best?

Hansen AR, Graham DM, Pond GR, Siu LL. Hansen AR, et al. Among authors: siu ll. Cancer Control. 2014 Jul;21(3):200-8. doi: 10.1177/107327481402100304. Cancer Control. 2014. PMID: 24955703 Free article. Review.

2

Principles of clinical trial design.

Nottage M, Siu LL. Nottage M, et al. Among authors: siu ll. J Clin Oncol. 2002 Sep 15;20(18 Suppl):42S-6S. J Clin Oncol. 2002. PMID: 12235224 Review. No abstract available.

3

Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.

Ma BB, Tannock IF, Pond GR, Edmonds MR, Siu LL. Ma BB, et al. Among authors: siu ll. Cancer. 2002 Dec 15;95(12):2516-23. doi: 10.1002/cncr.10995. Cancer. 2002. PMID: 12467065 Free article.

4

Clinical trial designs for targeted agents.

Ma BB, Britten CD, Siu LL. Ma BB, et al. Among authors: siu ll. Hematol Oncol Clin North Am. 2002 Oct;16(5):1287-305. doi: 10.1016/s0889-8588(02)00045-x. Hematol Oncol Clin North Am. 2002. PMID: 12512393 Review.

5

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.

Nottage M, McLachlan SA, Brittain MA, Oza A, Hedley D, Feld R, Siu LL, Pond G, Moore MJ. Nottage M, et al. Among authors: siu ll. Support Care Cancer. 2003 Jan;11(1):41-7. doi: 10.1007/s00520-002-0378-8. Epub 2002 Jul 23. Support Care Cancer. 2003. PMID: 12527953 Clinical Trial.

6

Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns.

Townsley CA, Naidoo K, Pond GR, Melnick W, Straus SE, Siu LL. Townsley CA, et al. Among authors: siu ll. J Clin Oncol. 2003 Dec 15;21(24):4627-35. doi: 10.1200/JCO.2003.06.073. J Clin Oncol. 2003. PMID: 14673052

7

Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience.

Knox JJ, Hedley D, Oza A, Siu LL, Pond GR, Moore MJ. Knox JJ, et al. Among authors: siu ll. Ann Oncol. 2004 May;15(5):770-4. doi: 10.1093/annonc/mdh172. Ann Oncol. 2004. PMID: 15111345 Free article. Clinical Trial.

8

Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status.

Bahl M, Siu LL, Pond GR, Kim J, Tannock IF, Bayley A, Cummings BJ, Waldron J, Ringash J, Chen EX, Gitterman L, Lemon B, O'Sullivan B. Bahl M, et al. Among authors: siu ll. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1127-36. doi: 10.1016/j.ijrobp.2004.05.011. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519784

9

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.

Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A, Siu LL. Hotte SJ, et al. Among authors: siu ll. J Clin Oncol. 2005 Jan 20;23(3):585-90. doi: 10.1200/JCO.2005.06.125. J Clin Oncol. 2005. PMID: 15659505 Clinical Trial.

10

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E, Nematollahi M, Pond GR, Zhang J, Moore MJ. Knox JJ, et al. Among authors: siu ll. J Clin Oncol. 2005 Apr 1;23(10):2332-8. doi: 10.1200/JCO.2005.51.008. J Clin Oncol. 2005. PMID: 15800324 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page